Muyldermans S - Search Results

1

Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.

Evazalipour M, D'Huyvetter M, Tehrani BS, Abolhassani M, Omidfar K, Abdoli S, Arezumand R, Morovvati H, Lahoutte T, Muyldermans S, Devoogdt N. Evazalipour M, et al. Among authors: muyldermans s. Contrast Media Mol Imaging. 2014 May-Jun;9(3):211-20. doi: 10.1002/cmmi.1558. Contrast Media Mol Imaging. 2014. PMID: 24700748 Free article.

2

Nanobodies as tools for in vivo imaging of specific immune cell types.

De Groeve K, Deschacht N, De Koninck C, Caveliers V, Lahoutte T, Devoogdt N, Muyldermans S, De Baetselier P, Raes G. De Groeve K, et al. Among authors: muyldermans s. J Nucl Med. 2010 May;51(5):782-9. doi: 10.2967/jnumed.109.070078. Epub 2010 Apr 15. J Nucl Med. 2010. PMID: 20395332 Free article.

3

In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.

Vaneycken I, Govaert J, Vincke C, Caveliers V, Lahoutte T, De Baetselier P, Raes G, Bossuyt A, Muyldermans S, Devoogdt N. Vaneycken I, et al. Among authors: muyldermans s. J Nucl Med. 2010 Jul;51(7):1099-106. doi: 10.2967/jnumed.109.069823. Epub 2010 Jun 16. J Nucl Med. 2010. PMID: 20554727 Free article.

4

Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.

Gainkam LO, Keyaerts M, Caveliers V, Devoogdt N, Vanhove C, Van Grunsven L, Muyldermans S, Lahoutte T. Gainkam LO, et al. Among authors: muyldermans s. Mol Imaging Biol. 2011 Oct;13(5):940-8. doi: 10.1007/s11307-010-0428-4. Mol Imaging Biol. 2011. PMID: 20865332

5

Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice.

Gainkam LO, Caveliers V, Devoogdt N, Vanhove C, Xavier C, Boerman O, Muyldermans S, Bossuyt A, Lahoutte T. Gainkam LO, et al. Among authors: muyldermans s. Contrast Media Mol Imaging. 2011 Mar-Apr;6(2):85-92. doi: 10.1002/cmmi.408. Epub 2010 Oct 9. Contrast Media Mol Imaging. 2011. PMID: 20936711 Free article.

6

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.

Vaneycken I, Devoogdt N, Van Gassen N, Vincke C, Xavier C, Wernery U, Muyldermans S, Lahoutte T, Caveliers V. Vaneycken I, et al. Among authors: muyldermans s. FASEB J. 2011 Jul;25(7):2433-46. doi: 10.1096/fj.10-180331. Epub 2011 Apr 8. FASEB J. 2011. PMID: 21478264

7

Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy.

Van de Broek B, Devoogdt N, D'Hollander A, Gijs HL, Jans K, Lagae L, Muyldermans S, Maes G, Borghs G. Van de Broek B, et al. Among authors: muyldermans s. ACS Nano. 2011 Jun 28;5(6):4319-28. doi: 10.1021/nn1023363. Epub 2011 Jun 10. ACS Nano. 2011. PMID: 21609027 Free article.

8

Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Caljon G, Caveliers V, Lahoutte T, Stijlemans B, Ghassabeh GH, Van Den Abbeele J, Smolders I, De Baetselier P, Michotte Y, Muyldermans S, Magez S, Clinckers R. Caljon G, et al. Among authors: muyldermans s. Br J Pharmacol. 2012 Apr;165(7):2341-53. doi: 10.1111/j.1476-5381.2011.01723.x. Br J Pharmacol. 2012. PMID: 22013955 Free PMC article.

9

Nanobody-coupled microbubbles as novel molecular tracer.

Hernot S, Unnikrishnan S, Du Z, Shevchenko T, Cosyns B, Broisat A, Toczek J, Caveliers V, Muyldermans S, Lahoutte T, Klibanov AL, Devoogdt N. Hernot S, et al. Among authors: muyldermans s. J Control Release. 2012 Mar 10;158(2):346-53. doi: 10.1016/j.jconrel.2011.12.007. Epub 2011 Dec 16. J Control Release. 2012. PMID: 22197777 Free PMC article.

10

Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor.

Behdani M, Zeinali S, Khanahmad H, Karimipour M, Asadzadeh N, Azadmanesh K, Khabiri A, Schoonooghe S, Habibi Anbouhi M, Hassanzadeh-Ghassabeh G, Muyldermans S. Behdani M, et al. Among authors: muyldermans s. Mol Immunol. 2012 Feb;50(1-2):35-41. doi: 10.1016/j.molimm.2011.11.013. Epub 2011 Dec 29. Mol Immunol. 2012. PMID: 22208996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page